Table 2.
Description of the Flagships
| Name of ‘Flagship condition’ | Description | Test type | Number of genes | Number tested | Clinical disciplines |
|---|---|---|---|---|---|
| Childhood syndromes | Children (average age 2.5 years) with features suggestive of a single gene disorder. | Germline | 2820 | 142 | Medical geneticsa |
| Neonatology | |||||
| Paediatrics | |||||
| Inherited neuropathies | Adults, adolescents and children with a clinical diagnosis of Charcot–Marie–Tooth disease, a group of inherited neuropathies with a broad range of phenotypes, inheritance patterns and causative genes. | Germline | 55 | 50 (25 paediatric 25 adult) | Paediatric neurologya |
| Adult neurology | |||||
| Medical genetics | |||||
| hCRC | Adults with personal and/or family history meeting criteria for inherited syndromes causing colorectal cancer. | Germline | 17 | 35 | Gastroenterologya |
| Medical genetics | |||||
| Oncology | |||||
| Focal epilepsy | Adults, adolescents and children with focal epilepsy in the absence of a structural brain lesion or past history suggestive of previous brain insult | Germline | 59 | 41 (12 paediatric 29 adult) | Adult neurologya |
| Paediatric neurology | |||||
| Medical genetics | |||||
| AML | Patients with AML aged 70 or younger where the clinician considers that additional genomic testing may assist in understanding prognosis and/or contribute information for future treatment decisions. | Somatic | 12 | 45 (11 paediatric, 34 adult) | Adult haematologya Paediatric oncology |
hCRC hereditary colorectal cancer, AML acute myeloid leukaemia
a Clinical discipline of the flagship leader